Edition:
India

Anthera Pharmaceuticals Inc (ANTH.OQ)

ANTH.OQ on NASDAQ Stock Exchange Global Market

1.50USD
13 Dec 2017
Change (% chg)

$0.02 (+1.35%)
Prev Close
$1.48
Open
$1.47
Day's High
$1.55
Day's Low
$1.45
Volume
54,100
Avg. Vol
67,814
52-wk High
$16.96
52-wk Low
$1.21

Latest Key Developments (Source: Significant Developments)

Anthera Pharmaceuticals files for resale of up to 28.6 million shares of co's common stock
Tuesday, 14 Nov 2017 

Nov 13 (Reuters) - Anthera Pharmaceuticals Inc ::Anthera Pharmaceuticals Inc files for resale of up to 28.6 million shares of co's common stock by the selling stockholders‍​ .  Full Article

ANTHERA PHARMA REPORTS Q3 LOSS PER SHARE $0.58
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Anthera Pharmaceuticals Inc ::ANTHERA PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS 2017 THIRD QUARTER FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.58.‍ENDED Q3 OF 2017 WITH CASH AND CASH EQUIVALENTS TOTALING $6.1 MILLION, COMPARED TO $20.8 MILLION AS OF DECEMBER 31, 2016​.  Full Article

Anthera Pharmaceuticals announces pricing of $15 mln private placement offering
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Anthera Pharmaceuticals Inc :Anthera Pharmaceuticals announces pricing of $15 million private placement offering.Anthera Pharma - ‍To use net proceeds from offering for clinical research, development purposes for Sollpura, including result, simplicity, easy trials​.Anthera Pharmaceuticals Inc - ‍Investors have agreed to purchase 2.31 million shares of common stock at $1.25 per share​.  Full Article

Anthera announces positive DSMB review in phase 3 solution study of Sollpura
Tuesday, 16 Aug 2016 

Anthera Pharmaceuticals Inc : Announces positive DSMB review in phase 3 solution study of Sollpura .DSMB had "no concerns regarding safety of data to date, and voted that study continue without modification to protocol or charter.".  Full Article

Anthera Pharmaceuticals Q2 loss per share $0.35
Tuesday, 9 Aug 2016 

Anthera Pharmaceuticals Inc : Q2 loss per share $0.35 .Anthera Pharmaceuticals provides business update and reports 2016 second quarter financial results.  Full Article

Anthera Pharmaceuticals posts Q1 loss of $0.29/share
Monday, 9 May 2016 

Anthera Pharmaceuticals Inc : Anthera Pharmaceuticals provides business update and reports 2016 first quarter financial results . Q1 loss per share $0.29 .Says license and collaborative revenues for quarter ended March 31, 2016 totaled $145,000.  Full Article

Anthera Pharmaceuticals Announces Appointment of Craig Thompson as President and Chief Operating Officer
Wednesday, 6 Jan 2016 

Anthera Pharmaceuticals, Inc:Says appointment of Craig Thompson as President and Chief Operating Officer.Says appointment of Chuck Olson, D.Sc. to the position of Chief Technology Officer replacing Debra Odink, Ph.D. who will continue to support the company in a key advisory role.  Full Article

BRIEF-Anthera Pharmaceuticals Announces Positive Outcome In The Phase 3 Result Clinical Study Of Sollpura

* ANTHERA PHARMACEUTICALS ANNOUNCES POSITIVE OUTCOME OF INTERIM FUTILITY ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA